![Katie Gordon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Katie Gordon
Plus aucun poste en cours
Profil
Prior to joining Harvard's Office of Technology Development in 2004, Dr. Gorgon served as a consultant to several early-stage biomedical companies in the areas of strategic development and operations/management.
She previously founded and ran biotechnology company Apollo BioPharmaceutics, a neuroscience company that developed novel neuroprotective compounds for Alzheimer's disease and ophthalmic indications and was by acquired by MitoKor Corp.
Prior to Apollo/MitoKor, she was a Director at Genzyme Corporation.
Dr. Gordon was a post-doctoral fellow at Yale University and holds a PhD from Wesleyan University.
Anciens postes connus de Katie Gordon
| Sociétés | Poste | Fin |
|---|---|---|
Office of Technology Development
 Office of Technology Development Investment ManagersFinance Office of Technology Development invests in companies located in the United States. The firm focuses on health and technology sectors. It participates in early-stage transactions. | Private Equity Investor | 30/06/2009 |
| LINEAGE CELL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/04/2006 |
Formation de Katie Gordon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Lineage Cell Therapeutics, Inc.
 Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Wesleyan University
 Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development invests in companies located in the United States. The firm focuses on health and technology sectors. It participates in early-stage transactions. | Finance |
